CYT
Cyteir Therapeutics, Inc. Common Stock
CYT
CYT
Delisted
CYT was delisted on the 15th of March, 2024.
30 hedge funds and large institutions have $28.5M invested in Cyteir Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
Holders
30
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$604K | |
| 2 | +$99.2K | |
| 3 | +$49.7K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$34.7K |
| 5 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$23.8K |
Top Sellers
| 1 | -$953K | |
| 2 | -$259K | |
| 3 | -$250K | |
| 4 |
BlackRock
New York
|
-$194K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$67K |